In one patient (SM0010 [UM]), RPPA revealed significantly elevated levels of EGFR Y1173 phosphorylation, but genomics analyses of this patient’s tumor did not identify a genomic basis for EGFR activation. This evidence concerns the gene EGFR and neoplasm.